Neoplasms Research at Universitaet Rostock
The department of Medizinische Klinik III für Hämatologie, Onkologie und Palliativmedizin concentrates on blood‑related cancers, seeking better therapies for both adult and pediatric patients.
- Acute Myeloid Leukemia (AML)
- Relapsed Acute Lymphoblastic Leukemia (ALL)
- Optimization of chemotherapy dosing
- Evaluation of novel agents such as L‑Annamycin
- Assessment of bortezomib‑based induction regimens
Current studies aim to raise complete remission rates and define the most effective dosage schedules, offering new hope for patients with high‑risk or refractory disease at this European research site.
